Product analysis
Focus may support short-term alertness and calm attention through caffeine and theanine. It also contains an unapproved stimulant associated with anxiety and heart-rate effects, which raises a concrete concern about suitability.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality34
The rhodiola species is identified, while many other preparations remain unspecified. That species detail does not establish equivalence to particular extracts used in research.
Ingredient Transparency76
Declared amounts are listed, but many exact forms are unspecified. Different caffeine declarations also leave the total caffeine exposure unresolved.
Value For Money31
The serving cost looks more favorable for deanol than for caffeine, theanine, rhodiola or lion's mane. Value for several other components remains uncertain.
Customer Satisfaction71
Customers give favorable ratings, but the number of ratings is small. That leaves a limited picture of satisfaction and does not establish safety.
Product Focus66
Caffeine gives the clearest connection to acute alertness, with limited support from theanine for calm attention. The unapproved stimulant and its anxiety and heart-rate concerns weaken the practical case for the combination.
- Format
Capsule - Container
- 240 Capsule(s)
- Per serving
- $1.59
- Customer rating
- 4.7 · 56 ratings
Goals
No linked studies yet.
No linked studies yet.
No linked studies yet.
No linked studies yet.
No linked studies yet.
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
L-Tyrosine | 2000 mg | |
Lion's Mane Mushroom, Powder | 800 mg | |
DMAE (2-Dimethylaminoethanol Bitartrate) | 750 mg | |
Alpha GPC | 600 mg | |
Rhodiola rosea extract (Rosavins) | 400 mg | |
Ginkgo biloba extract | 300 mg | |
N-Phenethyl Dimethylamine | 250 mg | |
Caffeine Anhydrous | 200 mg | |
Di-Caffeine Malate | 150 mg | |
L-Theanine | 150 mg | |
Huperzine A (Huperzia serrata Leaf Extract) | 20 mg | |
Bioperine (Black Pepper Fruit Extract) | 10 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability80
Isomer Specificity (L-Theanine)
Branded Forms & Purity Standards
Dose, Safety & Label Transparency100
Theanine Dosage Efficacy
Label Transparency & Blends
Value20
Price per 100mg L-Theanine
How this ingredient is rated
Active Ingredient Quality & Bioavailability85
Tyrosine Chemical Form
Purity and Sourcing Signals
Dose, Safety & Label Transparency86
Tyrosine Dosage Adequacy
Label Transparency and Blends
Value40
Price per Gram of Tyrosine
How this ingredient is rated
Composition and Label Disclosure68
Declared Rhodiola Marker Profile
Rhodiola Species Detail
Composition and Label Disclosure70
Rhodiola Amount Disclosure
Other Ingredients Disclosure
Commercial Price and Usability20
Cost per 200 mg Declared Rhodiola
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
- Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance.
- Improvement of cognitive functions by oral intake of Hericium erinaceus.
- Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.
- A review of the effects of mushrooms on mood and neurocognitive health across the lifespan.
- Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.